End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.57 NOK | -8.06% | -1.04% | -32.94% |
Business Summary
Number of employees: 21
Sales per Business
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostics Test Products
68.0
%
| 9 | 79.6 % | 10 | 68.0 % | +8.19% |
Diagnostics Test Services
21.3
%
| 1 | 8.8 % | 3 | 21.3 % | +206.96% |
Platform Installation
10.7
%
| 1 | 11.6 % | 2 | 10.7 % | +17.17% |
Sales per region
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
51.8
%
| 8 | 67.2 % | 7 | 51.8 % | -2.37% |
Europe
33.4
%
| 2 | 21.2 % | 5 | 33.4 % | +99.16% |
Rest of World
14.9
%
| 1 | 11.6 % | 2 | 14.9 % | +62.79% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronny Hermansen
CEO | Chief Executive Officer | 62 | 31/03/14 |
Eilert Aamodt
DFI | Director of Finance/CFO | 54 | 31/12/20 |
Lars Tiller
COO | Chief Operating Officer | - | 03/03/22 |
Kari Furu
CTO | Chief Tech/Sci/R&D Officer | 44 | 31/12/15 |
Christina Casèn
CTO | Chief Tech/Sci/R&D Officer | 64 | 31/12/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rune Sørum
BRD | Director/Board Member | 68 | 31/12/09 |
Director/Board Member | 66 | 31/12/19 | |
Per Matsson
CHM | Chairman | 70 | - |
Andrew Stapleton
BRD | Director/Board Member | 68 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,199,319 | 17,011,475 ( 44.53 %) | 0 | 44.53 % |
Company contact information
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.94% | 2.41M | |
-17.86% | 8.3B | |
+49.55% | 3.78B | |
-8.23% | 2.47B | |
-34.62% | 2.46B | |
-9.24% | 2.31B | |
-4.14% | 1.95B | |
-17.46% | 1.59B | |
-37.88% | 1.21B | |
+8.08% | 1.1B |
- Stock Market
- Equities
- GEAN Stock
- Company Genetic Analysis